Login to Your Account



Post-Questcor, Mallinckrodt pays $100M to settle Acthar antitrust charge

By Marie Powers
News Editor

Thursday, January 19, 2017

Acthar Gel was the centerpiece of Mallinckrodt plc’s $5.6 billion acquisition of Questcor Pharmaceuticals Inc. in 2014 but also triggered alarm bells in some quarters for its fast-growing price.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription